2024 16th Annual Sentinel Initiative Public Workshop

The Annual Sentinel Initiative Public Workshop is a gathering of the Sentinel community and leading experts to share recent developments within the Sentinel Initiative and to promote engagement and collaboration with the public health community. The Duke-Margolis Institute for Health Policy hosted the 16th Annual Sentinel Initiative Public Workshop under a cooperative agreement with the Food and Drug Administration (FDA) on November 7, 2024, from 9:00 AM - 4:15 PM ET. This workshop was a hybrid event.

This hybrid, public workshop featured a keynote from Patrizia Cavazzoni, Director of the FDA's Center for Drug Evaluation and Research. Participants also heard from Sentinel Initiative leadership on various key issues illustrated by exemplary use cases. Sessions focused on key progress made and upcoming opportunities for the Sentinel System, BEST System, and the landscape of community engagement.

This meeting is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award U01FD006807 totaling $2,575,023 with 100 percent funded by FDA/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.